INTRODUCTION: We retrospectively analyzed 6 cases of adrenal cortical carcinoma (ACC) treated during a 12-year period at a single institution. PATIENTS AND METHODS: We reviewed the clinical and pathological records and updated the follow-up of the patients treated and observed in our institution between 1995 and 2006. RESULTS: All 6 patients underwent surgery for ACC. The mean age at diagnosis was 53.3 years (range 36-72). The median follow-up was 50.7 months (range 13-132). Three patients were clinically classified as stage II, 2 as stage III and 1 as stage IV with bone metastasis. The 5-year overall survival was 62.5%. Recurrences or metastases occurred in 4 patients. Two patients without reoperation for metastases died, and others with radical treatments such as surgery, chemotherapy, transcatheter arterial embolization and/or radiation remain alive. CONCLUSIONS: In our experience, transcatheter arterial embolization was effective against liver metastasis. Copyright 2009 S. Karger AG, Basel.
INTRODUCTION: We retrospectively analyzed 6 cases of adrenal cortical carcinoma (ACC) treated during a 12-year period at a single institution. PATIENTS AND METHODS: We reviewed the clinical and pathological records and updated the follow-up of the patients treated and observed in our institution between 1995 and 2006. RESULTS: All 6 patients underwent surgery for ACC. The mean age at diagnosis was 53.3 years (range 36-72). The median follow-up was 50.7 months (range 13-132). Three patients were clinically classified as stage II, 2 as stage III and 1 as stage IV with bone metastasis. The 5-year overall survival was 62.5%. Recurrences or metastases occurred in 4 patients. Two patients without reoperation for metastases died, and others with radical treatments such as surgery, chemotherapy, transcatheter arterial embolization and/or radiation remain alive. CONCLUSIONS: In our experience, transcatheter arterial embolization was effective against liver metastasis. Copyright 2009 S. Karger AG, Basel.
Authors: Dwight H Owen; Sandipkumar Patel; Lai Wei; John E Phay; Lawrence A Shirley; Lawrence S Kirschner; Carl Schmidt; Sherif Abdel-Misih; Pamela Brock; Manisha H Shah; Bhavana Konda Journal: Horm Cancer Date: 2019-08-29 Impact factor: 3.869
Authors: André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri Journal: Crit Rev Oncol Hematol Date: 2014-06-04 Impact factor: 6.312
Authors: Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer Journal: Endocr Rev Date: 2013-12-20 Impact factor: 19.871
Authors: Gergely Huszty; Attila Doros; Katalin Farkas; László Kóbori; Péter Reismann; Judit Tőke; Miklós Tóth; Peter Igaz Journal: Front Endocrinol (Lausanne) Date: 2021-04-30 Impact factor: 5.555
Authors: Michal Mauda-Havakuk; Elizabeth Levin; Elliot B Levy; Venkatesh P Krishnasamy; Victoria Anderson; Nidhi Jain; Hayet Amalou; Tito Fojo; Maureen Edgerly; Paul G Wakim; Marybeth S Hughes; Jaydira Del Rivero; Bradford J Wood Journal: Cancer Med Date: 2021-03-09 Impact factor: 4.711
Authors: Yun Mi Choi; Hyemi Kwon; Min Ji Jeon; Tae-Yon Sung; Suck Joon Hong; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jae Lyun Lee; Dong Eun Song; Won Gu Kim Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889